Researchers Evaluate Smoking Cessation Drug, Varenicline

In a recent study published in the November issue of The Journal of Clinical Pharmacology, researchers from Pfizer Global Research and Development report on the first clinical trial studying the safety, tolerability, and pharmacokinetics of the drug varenicline on 65 to 75 year-old smokers.

CMS Approves SeQual

SeQual Technologies Inc, San Diego, announced today that health providers nationwide will now be reimbursed by Medicare for the portable portion of their use of SeQual’s Eclipse Oxygen System. Prior to the decision by the Centers for Medicare & Medicaid Services (CMS), providers could only bill Medicare for the Eclipse’s use as a stationary concentrator.

Smokers at Increased Risk for COPD

One-quarter of long-term smokers are likely to develop chronic obstructive pulmonary disease (COPD), according to Danish researchers.

New Asthma Medicine Targeting Vulnerable Inner-City Children Tested

University of Texas (UT) Southwestern Medical Center is one of a handful of top research institutions evaluating a promising new medication that researchers hope can reduce the severity and frequency of asthma attacks in inner-city children, a population known to have a high prevalence of severe asthma.

Potential New Therapeutic Target for Asthma

Virginia Commonwealth University (VCU) researchers have identified how a bioactive molecule involved with allergy, inflammation, and cancer is transported out of mast cells, according to findings published online this week in the Proceedings of the National Academy of Sciences.